Pulmonx Operating Expenses 2019-2025 | LUNG
Pulmonx operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
| Pulmonx Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $141 |
| 2023 | $131 |
| 2022 | $112 |
| 2021 | $96 |
| 2020 | $65 |
| 2019 | $50 |
| 2018 | $35 |
| Pulmonx Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-06-30 | $39 |
| 2025-03-31 | $37 |
| 2024-12-31 | $37 |
| 2024-09-30 | $35 |
| 2024-06-30 | $36 |
| 2024-03-31 | $33 |
| 2023-12-31 | $33 |
| 2023-09-30 | $33 |
| 2023-06-30 | $34 |
| 2023-03-31 | $31 |
| 2022-12-31 | $30 |
| 2022-09-30 | $27 |
| 2022-06-30 | $28 |
| 2022-03-31 | $26 |
| 2021-12-31 | $26 |
| 2021-09-30 | $23 |
| 2021-06-30 | $25 |
| 2021-03-31 | $22 |
| 2020-12-31 | $19 |
| 2020-09-30 | $16 |
| 2020-06-30 | $15 |
| 2020-03-31 | $15 |
| 2019-12-31 | |
| 2019-09-30 | $13 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.064B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.855B | 58.34 |
| Tempus AI (TEM) | United States | $12.818B | 0.00 |
| Doximity (DOCS) | United States | $12.199B | 54.28 |
| Hims & Hers Health (HIMS) | United States | $10.401B | 85.22 |
| IRhythm Technologies (IRTC) | United States | $5.159B | 0.00 |
| Hinge Health (HNGE) | United States | $4.608B | 0.00 |
| Privia Health (PRVA) | United States | $2.610B | 193.36 |
| Inspire Medical Systems (INSP) | United States | $2.596B | 38.16 |
| Heartflow (HTFL) | $2.530B | 0.00 | |
| Phreesia (PHR) | United States | $1.708B | 0.00 |
| Enovis (ENOV) | United States | $1.689B | 8.93 |
| 10x Genomics (TXG) | United States | $1.663B | 0.00 |
| Omnicell (OMCL) | United States | $1.456B | 28.04 |
| Schrodinger (SDGR) | United States | $1.426B | 0.00 |
| Azenta (AZTA) | United States | $1.393B | 60.78 |
| Clover Health Investments (CLOV) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.092B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.491B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.429B | 128.00 |
| Carlsmed (CARL) | $0.360B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.360B | 0.00 |
| TruBridge (TBRG) | United States | $0.289B | 50.74 |
| Outset Medical (OM) | United States | $0.236B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.205B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.193B | 0.00 |
| CapsoVision (CV) | United States | $0.178B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.135B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.110B | 5.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
| 111 (YI) | China | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |